- Report
- August 2025
- 180 Pages
Global
From €3171EUR$3,545USD£2,788GBP
€3524EUR$3,939USD£3,098GBP
- Report
- August 2025
- 191 Pages
Global
From €3171EUR$3,545USD£2,788GBP
€3524EUR$3,939USD£3,098GBP
- Report
- August 2025
- 180 Pages
Global
From €3171EUR$3,545USD£2,788GBP
€3524EUR$3,939USD£3,098GBP
- Report
- August 2025
- 189 Pages
Global
From €3171EUR$3,545USD£2,788GBP
€3524EUR$3,939USD£3,098GBP
- Report
- August 2025
- 199 Pages
Global
From €3171EUR$3,545USD£2,788GBP
€3524EUR$3,939USD£3,098GBP
- Report
- August 2025
- 183 Pages
Global
From €3171EUR$3,545USD£2,788GBP
€3524EUR$3,939USD£3,098GBP
- Report
- August 2025
- 183 Pages
Global
From €3171EUR$3,545USD£2,788GBP
€3524EUR$3,939USD£3,098GBP
- Report
- May 2025
- 115 Pages
Global
From €4249EUR$4,750USD£3,736GBP
- Report
- July 2025
- 175 Pages
Global
From €4017EUR$4,490USD£3,532GBP
- Report
- January 2025
- 250 Pages
Global
From €4017EUR$4,490USD£3,532GBP
- Report
- March 2025
- 182 Pages
Global
From €4026EUR$4,500USD£3,539GBP
- Report
- January 2025
- 180 Pages
Global
From €4026EUR$4,500USD£3,539GBP
- Report
- January 2025
- 185 Pages
Global
From €4026EUR$4,500USD£3,539GBP
- Report
- October 2025
- 191 Pages
Global
From €3171EUR$3,545USD£2,788GBP
€3524EUR$3,939USD£3,098GBP
- Report
- October 2025
- 192 Pages
Global
From €3171EUR$3,545USD£2,788GBP
€3524EUR$3,939USD£3,098GBP
- Report
- October 2025
- 181 Pages
Global
From €3171EUR$3,545USD£2,788GBP
€3524EUR$3,939USD£3,098GBP
- Report
- August 2025
- 184 Pages
Global
From €3171EUR$3,545USD£2,788GBP
€3524EUR$3,939USD£3,098GBP
- Report
- August 2025
- 196 Pages
Global
From €3171EUR$3,545USD£2,788GBP
€3524EUR$3,939USD£3,098GBP
- Report
- August 2025
- 190 Pages
Global
From €3171EUR$3,545USD£2,788GBP
€3524EUR$3,939USD£3,098GBP
- Report
- October 2025
- 250 Pages
Global
From €4017EUR$4,490USD£3,532GBP

Glaucoma is a group of eye diseases that damage the optic nerve, leading to vision loss. It is the leading cause of irreversible blindness worldwide. The glaucoma market within the optical industry is focused on providing treatments and technologies to diagnose and manage the disease. This includes medications, laser treatments, and surgical procedures. Additionally, the market includes devices such as tonometers, optical coherence tomography (OCT) systems, and visual field analyzers. These devices are used to measure intraocular pressure, detect structural changes in the eye, and assess the extent of vision loss.
Companies in the glaucoma market include Allergan, Bausch + Lomb, Carl Zeiss Meditec, Ellex, Glaukos, Hoya, Nidek, Topcon, and Ziemer Ophthalmic Systems. Show Less Read more